Author:
Zöllner N.,Kaiser W.,Göbner W.,Griebsch G.,Mertz D. P.
Publisher
Springer Berlin Heidelberg
Reference497 articles.
1. Alexander, S., Brendler, H.: Treatment of uric acid urolithiasis with allopurinol, a xanthine oxidase inhibitor. J. Urol. 97, 340–343 (1967).
2. Altman, K.I., Smull, K., Guzman-Barron, E.S.: A new method for the preparation of uricase and the effect of uricase on the blood uric acid levels of the chicken. Arch. Biochem. 21, 158–165 (1949).
3. Anderson, E.E., Rundles, R.W., Solberman, H.R., Metz, E.N.: Allopurinol control of hyperuricosuria: a new concept in the prevention of uric acid stones. J. Urol. 97, 344–347 (1967).
4. Auscher, C., Mercier, N., Pasquier, C., Delbarre, F.: Allopurinol and thiopurinol: effect in vivo on uricary oxypurine excretion and rate of synthesis of their ribonucleotides in different enzymatic deficiencies. In: Sperling, O., deVries, A., Wyngaarden, J.B. (Eds.): Advances in Experimental Medicine and Biology. Vol.41 B. Purine metabolism in man, pp.657–662. New York-London: Plenum Press 1974.
5. Band, P.R., Silverberg, D.S., Henderson, J.F., Ulan, R.A., Wensel, R.H., Banerjee, T.K., Little, A.S.: Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. New. Engl. J. Med. 283, 354–357 (1970).